Selected for HVC Kyoto 2025

DLeader was selected for HVC KYOTO 2025, one of Japan's leading healthcare venture programs, organized with the support of JETRO and Kyoto Research Park. The 2025 cohort brought together 12 startups and 10 researchers.

HVC KYOTO connects promising healthcare startups with investors, pharmaceutical companies and global partners. We are honored to be selected and look forward to building new collaborations to advance KumiChem™, our AI platform for RNA drug discovery.